956:HKEXChina Suntien Green Energy Corporation Limited Class H Analysis
Data as of 2026-05-21 - not real-time
SAR 8.10
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is currently trading near its 20‑day simple moving average, which sits just below the 50‑day average, indicating a neutral technical stance. The 200‑day average remains lower, providing a long‑term support cushion. Momentum indicators show an mid‑range RSI, suggesting neither overbought nor oversold conditions. The MACD line has crossed slightly above its signal, producing a modest bullish histogram, but the signal remains weak. Volume has been on a downward trend, reflecting dwindling market participation. The price is confined between a clear support level and a resistance ceiling identified by recent price action.
Fundamentally, the company posted a decline in revenue and thin gross margins, placing it in a value‑oriented profile. Profitability metrics such as ROE are respectable, while the payout ratio leaves ample room for dividend continuity. Cash on hand comfortably exceeds debt, and the low debt‑to‑equity ratio reduces financial strain. However, a discounted cash‑flow model values the business far below the current market price, flagging a substantial overvaluation. Volatility over the past month is elevated, and the beta is effectively neutral, implying price swings are driven more by company‑specific factors than market moves. With an attractive dividend yield and a sustainable payout, the stock may appeal to income‑focused investors despite the pricing gap.
Fundamentally, the company posted a decline in revenue and thin gross margins, placing it in a value‑oriented profile. Profitability metrics such as ROE are respectable, while the payout ratio leaves ample room for dividend continuity. Cash on hand comfortably exceeds debt, and the low debt‑to‑equity ratio reduces financial strain. However, a discounted cash‑flow model values the business far below the current market price, flagging a substantial overvaluation. Volatility over the past month is elevated, and the beta is effectively neutral, implying price swings are driven more by company‑specific factors than market moves. With an attractive dividend yield and a sustainable payout, the stock may appeal to income‑focused investors despite the pricing gap.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price trading well above DCF estimate
- Decreasing volume indicating weakening short‑term demand
- Neutral technical signals lacking clear upside momentum
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable dividend provides income cushion
- Valuation gap suggests potential correction rather than upside
- Moderate volatility and neutral beta limit directional risk
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong cash position and low leverage support long‑term stability
- Income focus aligns with dividend yield
- Persistent overvaluation may limit capital appreciation
Key Metrics & Analysis
Financial Health
Revenue Growth-5.40%
Profit Margin10.29%
P/E Ratio12.7
ROE21.36%
ROA8.95%
Debt/Equity2.79
P/B Ratio2.5
Op. Cash FlowSAR25.1M
Free Cash FlowSAR3.9M
Technical Analysis
TrendNeutral
RSI44.2
SupportSAR 7.77
ResistanceSAR 8.38
MA 20SAR 8.21
MA 50SAR 8.26
MA 200SAR 7.60
MACDBullish
VolumeDecreasing
Fear & Greed Index90.43
Valuation
Fair ValueSAR 2.07
GradeOvervalued
TypeValue
Dividend Yield3.03%
Risk Assessment
Beta-0.03
Volatility25.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.